BACKGROUND: In this report, we describe a case of a patient with substance-induced anxiety disorder occurring after a single dose of 3,4-methylenedioxymethamphetamine. Furthermore, we describe the use and efficacy of the Primary Care Behavioral Health model, a collaborative approach to integrative primary mental health care, in evaluating and treating this rare mental health disorder. CASE PRESENTATION: Three days following ingestion of one dose of 3,4-methylenedioxymethamphetamine, a 35-year-old Hispanic man with no significant prior mental health history and no history of prior 3,4-methylenedioxymethamphetamine use presented to our hospital with severe, acute anxiety and panic symptoms. He was initially treated with a combination of behav...
Objective: There are reports of alprazolam-induced hypomanidmania. Here is a case report of a patien...
Novel psychoactive substance use is a major social concern. Their use may elicit or uncover unpredic...
Soraya S, Mahdavi M, Saeidi M, et al. Prevalence of anxiety disorders and its co-occurrence with sub...
Abstract Background In this report, we describe a case of a patient with substance-induced anxiety d...
BACKGROUND: In this report, we describe a case of a patient with substance-induced anxiety disorder ...
Aim: Our aim is to describe a previously unreported potential interaction of nalmefene with methylph...
BACKGROUND: Hallucinogen persisting perception disorder (HPPD) is a relatively unknown complication ...
Background: The abuse of narcotic drugs and psychotropic substances such as amphetamines and ecstasy...
Objectives: Rapid and fast growth of Methamphetamine in Iran has posed a new challenge for Iranian h...
Background: Epidemiological studies are necessary to develop diagnostic standards for mental disorde...
Methylphenidate is one of the classic amphetamines which can cause or exacerbate psychotic symptoms ...
Sibutramine is an antiobesity drug which has also an inbitor effect on NE and 5HT reuptake pumps. Th...
Objective. This is a review of the current treatments used to alleviate the psychotic symptoms assoc...
Olanzapine is a thienobenzodiazepine that blocks especially the serontonin (5-hydroxytryptamine [5-H...
Background: Methamphetamine use can produce symptoms almost indistinguishable from schizophrenia. Di...
Objective: There are reports of alprazolam-induced hypomanidmania. Here is a case report of a patien...
Novel psychoactive substance use is a major social concern. Their use may elicit or uncover unpredic...
Soraya S, Mahdavi M, Saeidi M, et al. Prevalence of anxiety disorders and its co-occurrence with sub...
Abstract Background In this report, we describe a case of a patient with substance-induced anxiety d...
BACKGROUND: In this report, we describe a case of a patient with substance-induced anxiety disorder ...
Aim: Our aim is to describe a previously unreported potential interaction of nalmefene with methylph...
BACKGROUND: Hallucinogen persisting perception disorder (HPPD) is a relatively unknown complication ...
Background: The abuse of narcotic drugs and psychotropic substances such as amphetamines and ecstasy...
Objectives: Rapid and fast growth of Methamphetamine in Iran has posed a new challenge for Iranian h...
Background: Epidemiological studies are necessary to develop diagnostic standards for mental disorde...
Methylphenidate is one of the classic amphetamines which can cause or exacerbate psychotic symptoms ...
Sibutramine is an antiobesity drug which has also an inbitor effect on NE and 5HT reuptake pumps. Th...
Objective. This is a review of the current treatments used to alleviate the psychotic symptoms assoc...
Olanzapine is a thienobenzodiazepine that blocks especially the serontonin (5-hydroxytryptamine [5-H...
Background: Methamphetamine use can produce symptoms almost indistinguishable from schizophrenia. Di...
Objective: There are reports of alprazolam-induced hypomanidmania. Here is a case report of a patien...
Novel psychoactive substance use is a major social concern. Their use may elicit or uncover unpredic...
Soraya S, Mahdavi M, Saeidi M, et al. Prevalence of anxiety disorders and its co-occurrence with sub...